The F/M Emerald Life Sciences Innovation ETF (ticker: LFSC) is a dynamic investment vehicle tailored for those seeking exposure to cutting-edge advancements within the health care sector. This ETF is specifically concentrated on the Pharma, Biotech & Life Sciences niche, offering investors a unique opportunity to capitalize on the rapid innovation and growth potential in these fields. LFSC targets companies at the forefront of pharmaceutical development, biotechnology breakthroughs, and life sciences research, encompassing a broad spectrum of pioneering firms that are driving transformative changes in health care. With a focus on delivering strategic access to this vital segment, the F/M Emerald Life Sciences Innovation ETF is ideal for investors looking to diversify their portfolio with high-impact, future-focused investments that have the potential to redefine the health care landscape.
Asset Class
Equity
Region
North America
Issuer
F/m
Index Tracked
No Underlying Index
Ticker Symbol
LFSC
F/M Emerald Life Sciences Innovation ETF (LFSC) Fund Flow Chart
F/M Emerald Life Sciences Innovation ETF (LFSC) 1 year Net Flows: $3M
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.